Anti-peptidyl-arginine deaminase 3 (PAD3) antibodies as a promising marker to measure joint damage in patients with rheumatoid arthritis

Andrea Seaman, Erika Darrah, Maria Infantino, Francesca Meacci, Mariangela Manfredi, Maurizio Benucci, Michael Mahler

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Anti-peptidyl-arginine deaminase 3 (PAD3) antibodies as a promising marker to measure joint damage in patients with rheumatoid arthritis'. Together they form a unique fingerprint.

Medicine & Life Sciences